Nuclear Receptors in Liver Disease Δ

Cited by (261)

Items 101–200 of 261

1. A novel role of astrocyte elevated gene‐1 (AEG‐1) in regulating nonalcoholic steatohepatitis (NASH)
   Jyoti Srivastava, Chadia L. Robertson, Kareem Ebeid, Mikhail G. Dozmorov, Devaraja Rajasekaran, Rachel G. Mendoza, Ayesha Siddiq, Maaged Akiel, Nidhi H. Jariwala, Xue‐Ning Shen et al. · 2017 · Hepatology
2. Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
   Benoit Smeuninx, Ebru Boslem, Mark Anthony Febbraio · 2020 · Cancers
3. A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP‐2
   Yujie Li, Yongfeng Song, Meng Zhao, Yanjing Guo, Chunxiao Yu, Wenbin Chen, Shanshan Shao, Chao Xu, Xinli Zhou, Lifang Zhao et al. · 2017 · Hepatology
4. Liver and Gall Bladder
   Russell C. Cattley, John Michael Cullen · 2013 · Elsevier eBooks
5. Nuclear Receptors in Acute and Chronic Cholestasis
   Ester Gonzalez‐Sanchez, Delphine Firrincieli, Chantal Housset, Nicolas Chignard · 2015 · Digestive Diseases
6. Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice
   Chuanlong Zong, Yang Yu, Guohua Song, Tian Luo, Luqin Li, Xinnong Wang, Shucun Qin · 2012 · Experimental Biology and Medicine
7. Epigenomic regulation of bile acid metabolism: Emerging role of transcriptional cofactors
   Zachary Smith, Daniel Ryerson, Jongsook Kim Kemper · 2012 · Molecular and Cellular Endocrinology
8. Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
   Zhaolian Bian, Xiong Ma · 2012 · Frontiers in Physiology
9. RETRACTED: Protective Effect of Glycyrrhizic Acid on Alcoholic Liver Injury in Rats by Modulating Lipid Metabolism
   Xiaowei Huo, Sa Yang, Xiaoke Sun, Xiangbo Meng, Yanyan Zhao · 2018 · Molecules · Retracted
10. Integrating Drug’s Mode of Action into Quantitative Structure–Activity Relationships for Improved Prediction of Drug-Induced Liver Injury
    Leihong Wu, Zhichao Liu, Scott S. Auerbach, Ruili Huang, Minjun Chen, Kristin McEuen, Joshua Xu, Hong Fang, Weida Tong · 2017 · Journal of Chemical Information and Modeling
11. Hepatic retinoid stores are required for normal liver regeneration
    Igor O Shmarakov, Hongfeng Jiang, Kryscilla Jian Zhang Yang, Ira J. Goldberg, William S. Blaner · 2013 · Journal of Lipid Research
12. Transcriptome difference and potential crosstalk between liver and mammary tissue in mid-lactation primiparous dairy cows
    Dengpan Bu, Massimo Bionaz, Mengzhi Wang, Xuemei Nan, Lu Ma, Jiaqi Wang · 2017 · PLoS ONE
13. Identification of an Oleanane-Type Triterpene Hedragonic Acid as a Novel Farnesoid X Receptor Ligand with Liver Protective Effects and Anti-inflammatory Activity
    Yi Lu, Weili Zheng, Shengchen Lin, Fusheng Guo, Yanlin Zhu, Yijuan Wei, Xi Liu, Shikai Jin, Lihua Jin, Yong Li · 2017 · Molecular Pharmacology
14. The role of nuclear receptors in the kidney in obesity and metabolic syndrome
    Claudia Tovar‐Palacio, Nimbe Torres, Andrea Díaz‐Villaseñor, Armando Roberto Tovar · 2012 · Genes & Nutrition
15. Tetramethylpyrazine prevents ethanol-induced hepatocyte injury via activation of nuclear factor erythroid 2-related factor 2
    Chunfeng Lu, Yuanyuan Jiang, Feng Zhang, Jiangjuan Shao, Li Wu, Xiafei Wu, Naqi Lian, Lianyun Chen, Huanhuan Jin, Qin Chen et al. · 2015 · Life Sciences
16. Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking
    Chuanghong Wu, Richard K. Gilroy, Ryan M. Taylor, Mojtaba S. Olyaee, Bashar Abdulkarim, Jameson Forster, Maura F. O’Neil, Ivan Damjanov, Yu‐Jui Yvonne Wan · 2010 · Hepatology
17. Differential expression and glycative damage affect specific mitochondrial proteins with aging in rat liver
    Hilaire Bakala, Romain Ladouce, Martín A. Baraibar, Bertrand Friguet · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
18. Sorting out cirrhosis: mechanisms of non‐response to hepatitis C therapy
    Saeed H. Al Marzooqi, Jordan J. Feld · 2015 · Liver International
19. FXR Agonists: From Bench to Bedside, a Guide for Clinicians
    A. Alawad, C. Levy · 2016 · Digestive Diseases and Sciences
20. Roles of the inflammasome in the gut‑liver axis (Review)
    Junfeng Wang, Rui Dong, Shan Zheng · 2018 · Molecular Medicine Reports
21. Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters
    Keumhan Noh, Edwin C.Y. Chow, Holly P. Quach, Geny M. M. Groothuis, Rommel G. Tirona, K. Sandy Pang · 2022 · The AAPS Journal
22. Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy
    Katrin Panzitt, Peter Fickert, Martin Wagner · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
23. Effect of Chronic Western Diets on Non-Alcoholic Fatty Liver of Male Mice Modifying the PPAR-γ Pathway via miR-27b-5p Regulation
    Jian Zhang, Catherine A. Powell, Matthew Kay, Ravi Sonkar, Sunitha Meruvu, Mahua Choudhury · 2021 · International Journal of Molecular Sciences
24. Tanshinone IIA Downregulates Lipogenic Gene Expression and Attenuates Lipid Accumulation through the Modulation of LXRα/SREBP1 Pathway in HepG2 Cells
    Wan-Yun Gao, Pei‐Yi Chen, Hao‐Jen Hsu, Ching-Yen Lin, Ming‐Jiuan Wu, Jui-Hung Yen · 2021 · Biomedicines
25. Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis
    Ester Gonzalez‐Sanchez, Delphine Firrincieli, Chantal Housset, Nicolas Chignard · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26. Dysregulation of Kupffer Cells/Macrophages and Natural Killer T Cells in Steatohepatitis in LXRα Knockout Male Mice
    Kaori Endo‐Umeda, Hiroyuki Nakashima, Naoki Umeda, Shuhji Seki, Makoto Makishima · 2018 · Endocrinology
27. The role of glycerol-3-phosphate dehydrogenase 1 in the progression of fatty liver after acute ethanol administration in mice
    Tomoki Sato, Akihito Morita, Nobuko Mori, Shinji Miura · 2014 · Biochemical and Biophysical Research Communications
28. Xenobiotic-induced liver injury and fibrosis
    Christoph H. Österreicher, Michael A Trauner · 2012 · Expert Opinion on Drug Metabolism & Toxicology
29. Constitutive Androstane Receptor Differentially Regulates Bile Acid Homeostasis in Mouse Models of Intrahepatic Cholestasis
    Kim, Kang Ho, Choi, Jong Min, Li, Feng, Dong, Bingning, Wooton‐Kee, Clavia Ruth, Arizpe, Armando, Anakk, Sayeepriyadarshini, Jung, Sung Yun, Hartig, Sean M., Moore, David D. · 2019 · Hepatology Communications
30. Liver regeneration and alcoholic liver disease
    Yi Lv, Kwok‐Fai So, Jia Xiao · 2020 · Annals of Translational Medicine
31. Epigallocatechin gallate enhances biliary cholesterol secretion in healthy rats and lowers plasma and liver cholesterol in ethinylestradiol-treated rats
    Petra Hirsova, Gabriela Kolouchová, Eva Doleželová, Jolana Cermanová, Radomı́r Hyšpler, Zuzana Kadová, Stanislav Mičuda · 2012 · European Journal of Pharmacology
32. Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury
    Pan, Xue-yin, Wang, Ling, You, Hong-mei, Cheng, Miao, Yang, Yang, Huang, Cheng, Li, Jun · 2021 · Laboratory Investigation
33. Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury
    Yanqing Zhang, Cheng Wang, Yunli Tian, Fengxiao Zhang, Wenjing Xu, Xiangrao Li, Zhiping Shu, Yan Wang, Kai Huang, Dan Yang Huang · 2016 · American Journal Of Pathology
34. Disrupted Murine Gut–to–Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver Models
    Edwin C.Y. Chow, Holly P. Quach, Yueping Zhang, Jason Z. Y. Wang, David C. Evans, Albert P. Li, José de Paula Silva, Rommel G. Tirona, Yurong Lai, K. Sandy Pang · 2016 · Journal of Pharmacology and Experimental Therapeutics
35. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development
    Itzayana Rodríguez‐Antonio, Guillermo Nahúm López-Sánchez, Victor Y. Garrido-Camacho, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño‐Lámbarri · 2020 · HPB
36. Orostachys japonicus ameliorates acetaminophen-induced acute liver injury in mice
    Zixiong Zhou, Jing Qi, Jing Zhao, Jeong Hun Seo, Dong Gue Shin, Jeong‐Dan Cha, Chae Woong Lim, Jong-Won Kim, Bumseok Kim · 2020 · Journal of Ethnopharmacology
37. FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression
    Sai Wang, Rilu Feng, Shanshan Wang, Hui Liu, Chen Shao, Yujia Li, Frederik Link, Stefan Munker, Roman Liebe, Christoph Meyer et al. · 2022 · Gut
38. Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease
    Fernando E. Ezquer · 2015 · World Journal of Gastroenterology
39. Laboratory assessment of liver function and injury in children
    Vicky L. Ng · 2014 · Cambridge University Press eBooks
40. Dietary methionine deficiency stunts growth and increases fat deposition via suppression of fatty acids transportation and hepatic catabolism in Pekin ducks
    Yongbao Wu, Jing Tang, Zhiguo Wen, Bo Zhang, Junting Cao, Lulu Zhao, Zhanbao Guo, Ming Xie, Zhengkui Zhou, Shuisheng Hou · 2022 · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology
41. Farnesoid X receptor via Notch1 directs asymmetric cell division of Sox9+ cells to prevent the development of liver cancer in a mouse model
    Chen Mi, Chenxia Lu, Hanwen Lu, Junyi Zhang, Dan Qin, Shenghui Liu, Xiaodong Li, Lisheng Zhang · 2021 · Stem Cell Research & Therapy
42. Effect of cholecystectomy on bile acids as well as relevant enzymes and transporters in mice: Implication for pharmacokinetic changes of rifampicin
    Fan Zhang, Hongyan Qin, Yanshu Zhao, Yuhui Wei, Lili Xi, Zhi Rao, Jianping Zhang, Yanrong Ma, Yingting Duan, Xinan Wu · 2016 · European Journal of Pharmaceutical Sciences
43. Retinoids Modulate Thioacetamide-Induced Acute Hepatotoxicity
    Igor O Shmarakov, Vira L. Borschovetska, Mykhailo M. Marchenko, William S. Blaner · 2014 · Toxicological Sciences
44. Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR
    Jae Man Lee · 2016 · Annals of Pediatric Endocrinology & Metabolism
45. Ginkgolide B lowers body weight and ameliorates hepatic steatosis in high-fat diet-induced obese mice correlated with pregnane X receptor activation
    Lingling Luo, Yin Li, Dongshan Wang, Yuanyuan Zhao, Yahui Wang, Fei Li, Jinan Fang, Hui Chen, Shengjie Fan, Cheng Huang · 2017 · RSC Advances
46. The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease
    Randa Reda, Amal Ahmed Abbas, Mai Mohammed, Shahira Fathy El Fedawy, Hala Ghareeb, Rania Hamdy Elkabarity, Rania A. Abo‐Shady, Doaa Zakaria · 2015 · Journal of Immunology Research
47. Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK
    Yong Deuk Kim, Kwang Min Lee, Seung‐Lark Hwang, Hyeun Wook Chang, Keuk‐Jun Kim, Robert A. Harris, Hueng‐Sik Choi, Won-Sik Choi, Sung‐Eun Lee, Chul‐Seung Park · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
48. Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.
    Dong-Hun Lee, Dae Hwan Kim, C. J. Hwang, Sukgil Song, S. Han, Youngsoo Kim, Hwan-Soo Yoo, Young-Suk Jung, Soohyun Kim, D. Yoon et al. · 2015 · Clinical science
49. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells
    Asmita Pant, Elizabeth Ann Rondini, Thomas A. Kocarek · 2019 · Toxicology and Applied Pharmacology
50. Non-coding RNA crosstalk with nuclear receptors in liver disease
    Jianguo Wu, Laura E. Nagy, Suthat Liangpunsakul, Li Wang · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
51. Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors
    Ahmed Ghallab, Mattias Mandorfer, Guido Stirnimann, Joachim Geyer, Erik Lindström, Tom Luedde, Van der Merwe, Jassin Rashidi‐Alavijeh, Hartmut Schmidt, Saul J. Karpen et al. · 2025 · Journal of Hepatology
52. A large-scale human toxicogenomics resource for drug-induced liver injury prediction
    Volker Bergen, Konstantia R. Kodella, Sreenath Srikrishnan, Ornella Barrandon, Sara Anderson, Maximilian Rogers-Grazado, Casey C. Fowler, Hirit Beyene, Nicole Robichaud, Timothy Fulton et al. · 2025 · Nature Communications
53. Primary Sclerosing Cholangitis: New Approaches to Diagnosis, Surveillance and Treatment
    Michael A Trauner, Emina Halilbasic, Anna Baghdasaryan, Tarek Moustafa, Elisabeth Krones, Peter Fickert, Harald Hofer, Edward Penner · 2012 · Digestive Diseases
54. On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates
    Kim Frisch, Aage Kristian Olsen Alstrup · 2017 · Physiological and Biochemical Zoology
55. Genetic regulation of differentially methylated genes in visceral adipose tissue of severely obese men discordant for the metabolic syndrome
    F. Guénard, A. Tchernof, Y. Deshaies, S. Biron, O. Lescelleur, L. Biertho, S. Marceau, L. Pérusse, M. Vohl · 2017 · Translational research : the journal of laboratory and clinical medicine
56. Total saponins from Rosa laevigata Michx fruit attenuates hepatic steatosis induced by high-fat diet in rats
    Deshi Dong, Yan Qi, Lina Xu, Lianhong Yin, Youwei Xu, Xu Han, Yanyan Zhao, Jinyong Peng · 2014 · Food & Function
57. Basic Principles of Liver Physiology
    Valeria Casotti, Lorenzo D’Antiga · 2019 · Springer eBooks
58. Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
    Xiaofang Yang, Ming Lü, Lijiao You, Huan Gen, Lin Yuan, Tianning Tian, Chunyu Li, Kailiang Xu, Jie Hou, Ming Lei · 2021 · Chinese Medicine
59. New therapeutic targets in alcoholic hepatitis
    Diana Arsene, Omar Farooq, Ramon A. Bataller · 2016 · Hepatology International
60. Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression
    Wenjing Shang, Xiuming Liang, Shuyan Li, Tongyu Li, Lixin Zheng, Wei Shao, Yue Wang, Fen Liu, Lin Ma, Jihui Jia · 2020 · EBioMedicine
61. Farnesoid X Receptor Agonists: What They Are and How They Might Be Used in Treating Liver Disease
    Brent A. Neuschwander‐Tetri · 2011 · Current Gastroenterology Reports
62. MMARGE: Motif Mutation Analysis for Regulatory Genomic Elements
    Verena M. Link, Casey E. Romanoski, Dirk Metzler, Christopher K. Glass · 2018 · Nucleic Acids Research
63. Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults
    Sung‐Bum Lee, Yu‐Jin Kwon, Dong‐Hyuk Jung, Jong-Koo Kim · 2022 · International Journal of Environmental Research and Public Health
64. Association of Di(2-ethylhexyl) Terephthalate and Its Metabolites with Nonalcoholic Fatty Liver Disease: An Epidemiology and Toxicology Study
    Jiao-Yang Li, Rongbin Chen, Peng Liu, Xin Zhang, Yan Zhou, Yudong Xing, Xinhua Xiao, Zhenzhen Huang · 2024 · Environmental Science & Technology
65. Transcriptional Regulation of Hepatic Autophagy by Nuclear Receptors
    Eun Young Kim, Jae Man Lee · 2022 · Cells
66. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats
    Fan Zhang, Lili Xi, Yingting Duan, Hongyan Qin, Mengmeng Wei, Yanfang Wu, Boxia Li, Yan Zhou, Xinan Wu · 2018 · European Journal of Pharmaceutical Sciences
67. Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study
    Sandra Jose, Sreevidya S. Devi, Anjana Sajeev, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Abdulrahman Alshammari, Gautam Sethi, Ajaikumar Bahulayan Kunnumakkara · 2022 · Bioscience Reports
68. N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models
    Anna Cieślak, Jocelyn Trottier, Mélanie Verreault, Piotr Milkiewicz, Marie‐Claude Vohl, Olivier Barbier · 2018 · Canadian Journal of Gastroenterology and Hepatology
69. Exposure to 2,4-dichlorophenoxyacetic acid induced PPARβ-dependent disruption of glucose metabolism in HepG2 cells
    Haidong Sun, Wentao Shao, Hui Liu, Zhaoyan Jiang · 2018 · Environmental Science and Pollution Research
70. Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver disease
    Lingchong Liu, Yu Wang, Jing Zhang, Chao Wang, Youbao Li, Weichang Dai, Chunhong Piao, Junmei Liu, Hansong Yu, Xia Li et al. · 2021 · Food Reviews International
71. Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
    An-Na Moon, François Briand, Natália Martins Breyner, Dong Keun Song, Martin Rønn Madsen, Hongbin Kim, Keonwoo Choi, Yoonsuk Lee, Wan Namkung · 2024 · Biomedicine & Pharmacotherapy
72. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation
    Xiaohui Wang, Ting Fu, Junqiao Wang, Changyuan Wang, Kexin Liu, Jingjing Wu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, Qiang Meng · 2019 · International Immunopharmacology
73. Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
    Qingxue Liu, Lei Xu, Meifei Wu, Yiwen Zhou, Junfa Yang, Cheng Huang, Tao Xu, Jun Li, Lei Zhang · 2021 · Cell & Bioscience
74. Efficacy and safety of PPAR agonists in primary biliary cholangitis: a systematic review and meta-analysis of Randomized Controlled Trials
    Behrad Saeedian, Nastaran Babajani, Tannaz Bagheri, Fatemeh Ojaghi Shirmard, Seyed Morteza Pourfaraji · 2025 · BMC Gastroenterology
75. The Cumulative Risk Assessment of Hepatotoxic Chemicals: A Hepatic Histopathology Perspective
    John Reginald Foster, G. Semino Beninel, Stephanie Melching‐Kollmuss · 2020 · Toxicologic Pathology
76. Therapeutic Efficacy and Safety of Paeoniae Radix Rubra Formulae in Relieving Hyperbilirubinemia Induced by Viral Hepatitis: A Meta-Analysis
    Yin-Qiu Huang, Xiao Ma, Jian Wang, Yanling Zhao, Jiabo Wang, Zhe Chen, Yun Zhu, Limei Shan, Shizhang Wei, Ji Wang et al. · 2016 · Frontiers in Pharmacology
77. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury
    Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Veronica Siciliano, Vittoria Rizzo, Luciano Adorini, Plinio Richelmi, Mariapia Vairetti · 2018 · PLoS ONE
78. Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway
    Jingwen Zhao, Maojuan Ran, Ting Yang, Liwei Chen, Peixu Ji, Xiuxiu Xu, Lu Zhang, Siyuan Sun, Xin Liu, Simin Zhou et al. · 2021 · Frontiers in Pharmacology
79. Involvement of Autophagy in Ageing and Chronic Cholestatic Diseases
    Claudio Pinto, Elisabetta Ninfole, A. Benedetti, Marco Marzioni, Luca Maroni · 2021 · Cells
80. The role of nuclear receptors in metabolic homeostasis and disease: From molecular mechanisms to drug discovery
    Fangfang He, Haomeng Wu, Feilong Zhao, Xinxin Liu, Qinbo Yang, Shiquan Zhou, Tao Xu, Jing Xu, Shuai Wang, Denglang Zou · 2025 · Pharmacological Research
81. Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-Binding Domain
    A. Kosters, J. C. Felix, Moreshwar S. Desai, S. Karpen · 2013 · Journal of Hepatology
82. Do Therapeutic Bile Acids Hit the Sweet Spot of Glucose Metabolism in NAFLD?
    Saul J. Karpen · 2013 · Gastroenterology
83. Binding, activity and risk assessment of bisphenols toward farnesoid X receptor pathway: In vitro and in silico study
    Donghui Zhang, Xinya Liu, Yuan Qi, Yongfeng Lin, Kunming Zhao, Yuan Jin, Jiao Luo, Lin Xu, Dianke Yu, Chuanhai Li · 2023 · The Science of The Total Environment
84. Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis
    Hyelin Na, Ho Lee, Min-Ho Lee, Han Jeong Lim, Hyeonji Kim, Yoon Jeon, Hae-Lim Kang, Mi‐Ock Lee · 2016 · Life Sciences
85. Transient receptor potential canonical 5 channels plays an essential role in hepatic dyslipidemia associated with cholestasis
    Khadija M. Alawi, David Tandio, Jin Xu, Pratish Thakore, Georgia Papacleovoulou, Elizabeth Soares Fernandes, Cristina Legido‐Quigley, Catherine Williamson, Susan Diana Brain · 2017 · Scientific Reports
86. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
    Yuta Yoshimura, Masahide Hamaguchi, Yoshitaka Hashimoto, Takuro Okamura, Naoko Nakanishi, Akihiro Obora, Takao Kojima, Michiaki Fukui · 2021 · BMC Gastroenterology
87. Discovery of eukaryotic cellular receptor for Withaferin A, a multifaceted drug from Withania somnifera plant
    Varsha Dilip Shiragannavar, Nirmala G. Sannappa Gowda, Prasanna K. Santhekadur · 2022 · Medicine in Drug Discovery
88. Transcription Factors Potentially Involved in Regulation of Cytochrome P450 Gene Expression
    Piotr Czekaj, Rafa Skowronek · 2012 · InTech eBooks
89. Reduced FXR Target Gene Expression in Copper-Laden Livers of COMMD1-Deficient Dogs
    Xiaoyan Wu, Hsiao-Tzu Chien, Monique E. van Wolferen, Hedwig S. Kruitwagen, Loes A. Oosterhoff, Louis C. Penning · 2019 · Veterinary Sciences
90. Nuclear receptor gene alteration in human induced pluripotent stem cells with hepatic differentiation propensity
    Noriko Itaba, Peninah M. Wairagu, Natsumi Aramaki, Toshihiro Yasui, Yoshiaki Matsumi, Yohei Kono, Ai N. H. Phan, Makoto Otsu, Takahiro Kunisada, Yukio Nakamura et al. · 2014 · Hepatology Research
91. Mechanisms of bile formation and cholestasis
    Nikita A. Gupta, Saul J. Karpen · 2014 · Cambridge University Press eBooks
92. Effects of splenectomy on hepatic gene expression profiles after massive hepatectomy in rats
    Yusuke Arakawa, Mitsuo Shimada, Tohru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Chie Takasu · 2013 · Journal of Gastroenterology and Hepatology
93. Revealing the mechanism of Fructus meliae toosendan -induced liver injury in mice by integrating microRNA and mRNA-based toxicogenomics data
    Cai Ji, Jie Zheng, Wei Tong, Xiaoyan Lu, Xiaohui Fan, Yue Gao · 2015 · RSC Advances
94. Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction
    Leyi Liao, Ziying Liu, Lei Liu, Can Huang, Yiyi Li, Cungui Mao, Ruijuan Xu, Haiqing Liu, Cuiting Liu, Yonghong Peng et al. · 2025 · Nature Communications
95. SOCS1 regulates hepatic regenerative response and provides prognostic makers for acute obstructive cholangitis
    Jianhua Yu, Weiguang Zhang, Hongwei Qian, Haijun Tang, Weiguo Lin, Baochun Lu · 2017 · Scientific Reports
96. Role of Farnesoid X Receptor in the Determination of Liver Transcriptome during Postnatal Maturation in Mice
    Lai Peng, Stephanie C. Piekos, Grace L. Guo, Xiao-Bo Zhong · 2017 · Nuclear Receptor Research
97. Estrogen withdrawal and replacement differentially target liver and adipose tissues in female mice fed a high-fat high-sucrose diet: impact of a chronic exposure to a low-dose pollutant mixture☆
    Benoit Julien, Claudie Pinteur, Nathalie Véga, Hubert Vidal, Danielle Naville, Brigitte Le Magueresse‐Battistoni · 2019 · The Journal of Nutritional Biochemistry
98. Functional development of the liver
    Frederick J. Suchy · 2014 · Cambridge University Press eBooks
99. Nuclear receptors: how do they position in non‐alcoholic fatty liver disease treatment?
    Mariana Verdelho Machado, Helena Cortez‐Pinto · 2014 · Liver International
100. Alterations in bile acid metabolites associated with pathogenicity and IVIG resistance in Kawasaki disease
     Xinqi Wang, Linli Han, Jiyang Jiang, Zhenxin Fan, Yimin Hua, Libang He, Yifei Li · 2025 · Frontiers in Cardiovascular Medicine